The Netherlands: Frazier Health SPAC and NewAmsterdam Pharma to merge

NewAmsterdam Pharma Holding, a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases, and Frazier Lifesciences Acquisition Corporation (FLAC), a Nasdaq-listed blank cheque company sponsored by an affiliate of healthcare PE firm, Frazier Healthcare Partners, are combining to form NewAmsterdam Pharma Company. NewAmsterdam is expected to receive…

You must be a HMI Subscriber to view this content.

Subscribe Now »